Prof. Tiina Karu's Research Paper Written Exclusively For Us
Prof. Tiina Karu's Research Paper Written Exclusively For Us
Prof. Tiina Karu's Research Paper Written Exclusively For Us
(PHOTOBIOMODULATION)
T.I. KARU
More than 30 year ago the first publications about low-power laser therapy or
photobiomodulation (at that time called laser biostimulation) appeared. Since then
approximately 2000 studies have been published on this topic (analysis of these
publications can be found in [1]). Medical treatment with coherent light sources (lasers)
or noncoherent light (Light Emitting Diodes, LED's) has passed through its childhood
and early maturity. Photobiomodulation is being used by physiotherapists (to treat a
wide variety of acute and chronic muscosceletal aches and pains), dentists (to treat
inflamed oral tissues, and to heal diverse ulcerations), dermatologists (to treat oedema,
indolent ulcers, burns, dermatitis), rheumatologists (relief of pain, treatment of chronic
inflammations and autoimmune diseases), and by other specialists (e.g., for treatment of
middle and inner ear diseases, nerve regeneration). Photobiomodulation is also used in
veterinary medicine (especially in racehorse training centers) and in sports medicine
and rehabilitation clinics (to reduce swelling and hematoma, relief of pain and
improvement of mobility and for treatment of acute soft tissue injuries). Lasers and
LED's are applied directly to respective areas (e.g., wounds, sites of injuries) or to
various points on the body (acupuncture points, muscle trigger points). For details of
clinical applications and techniques used, the books [ 1-3] are recommended.
The GaAlAs diodes are used both in diode lasers and LED's, the difference is whether
the device contains the resonator (as the laser does) or not (LED). In latter years, longer
wavelengths (-800-900 nm) and higher output powers (to 100 mW) are preferred in
therapeutic devices.
Should a medical doctor use a laser or a diode? The answer is - it depends on what one
irradiates, in other words, how deep tissue layers must be irradiated. By light
interaction with a biotissue, coherent properties of laser light are not manifested at the
molecular level. The absorption of low-intensity laser light by biological systems is of a
purely noncoherent (i.e., photobiological) nature. On the cellular level, the biological
responses are determined by absorption of light with photoacceptor molecules (see the
section 3 below). Coherent properties of laser light are not important when cellular
monolayers, thin layers of cell suspension as well as thin layers of tissue surface are
irradiated (Fig. 1). In these cases, the coherent and noncoherent light (i.e., both lasers
and LED's) with the same wavelength, intensity and dose provides the same biological
response. Some additional (therapeutical) effects from the coherent and polarized
radiation (lasers) can occur in deeper layers of bulk tissue only and they are connected
with random interference of light waves. An interested reader is guided to the ref. [4]
for more details. Here we illustrate this situation by Fig. 1. Large volumes of tissue can
be irradiated by laser sources only because the length of longitudinal coherence Lcoh is
too small for noncoherent radiation sources [4].
When considering the cellular effects, this question can be answered by action spectra.
Any graph representing a photoresponse as a function of wavelength, wave number,
frequency, or photon energy, is called action spectrum. Action spectra have a highest
importance for identifying the photoacceptor inasmuch as the action spectrum of a
biological response resembles the absorption spectrum of the photoacceptor molecule.
Existence of a structured action spectrum is strong evidence that the phenomenon under
study is a photobiological one (i.e., primary photoacceptors and cellular signaling
pathways exist). Fig. 2 represents some examples of action spectra for eukaryotic cells:
two of them (A, B) consider the processes occurring in cell nucleus, and one spectrum
(C) is for cell membrane. Fig. 2D shows the absorption spectrum of the monolayer of
the same cells.
Fig. 2. Action spectra of: (A) DNA and (B) RNA synthesis rate in HeLa cells; (C)
plasma membrane adhesion of HeLa cells for red-to-near IR radiation; (D) absorption
spectrum of air-dried monolayer of HeLa cells for the same spectral region. Original
data can be found in ref. [5].
The spectra in Fig. 2 represent the red-to-near infrared (IR) region only, i.e. the region
that is most important for photobiomodulation. The action spectra for full visibleto-near
IR region can be found in [5]. In [5] one can find action spectra for various cellular
responses for other eukaryotic and prokaryotic cells as well.
Two conclusions can be drawn from action spectra in Fig. 2. First, the similarity of the
action spectra for different cellular responses suggests that the primary photoacceptor is
the same for all these responses. Second, the existence of the action spectra for
biochemical processes occurring in various cellular organelles (nucleus, Fig. 2A, B and
plasma membrane, Fig. 2C) assume the existence of cellular signaling pathways inside
of a cell between the photoacceptor and the nucleus as well as between the
photoacceptor and cell membrane. Action spectra also indicate, which wavelengths are
the best for irradiation: maximal biological responses are occurring when irradiated at
620, 680, 760 and 820-830 nm (maxima of the spectra in Fig. 2). Skipping over the
story of identifying the photoacceptor (described in [5]) let us conclude that
photoacceptor for eukaryotic cells in red-to-near IR region is believed to be the terminal
enzyme of the respiratory chain cytochrome c oxidase (located in cell mitochondrion).
To be more exact, it is a mixed valence (partially reduced) form of this enzyme, which
has not yet been identified. In the violet-to-blue spectral region, flavoproteins (e.g.,
NADHdehydrogenase in the beginning of the respiratory chain) are also among the
photoacceptors as well terminal oxidases.
An important point has to be emphasized. When the excitable cells (e.g., neurons,
cardiomyocites) are irradiated with monochromatic visible light, the photoacceptors are
also believed to be components of respiratory chain. Some of the experimental evidence
concerning excitable cells is shortly summarized in Fig. 3. It is quite clear from
experimental data (reviewed in [4]) that irradiation can cause physiological and
morphological changes in nonpigmental excitable cells via absorption in mitochondria.
Later, similar irradiation experiments were performed with neurons in connection with
low-power laser therapy. It was shown in 80's that He-Ne laser radiation alters the
firing pattern of nerves; it was also found that transcutaneous irradiation with HeNe
laser mimicked the effect of peripheral stimulation of a behavioral reflex. These
findings were found to be connected with pain therapy (review [4]).
So, what happens when the molecule of photoacceptor absorbs photons? Answer -
electronic excitation followed by photochemical reactions occurring from lower
excitation states (first singlet and triplet). It is also known that electronic excitation of
absorbing centers alters their redox properties. Until yet, five primary reactions have
been discussed in literature (Fig. 4). Two of them are connected with alteration of redox
properties and two mechanisms involve generation of reactive oxygen species (ROE).
Also, induction of local transient (very short time) heating of absorbing chromophors is
possible. Details of these mechanisms can be found in [4, 5].
There is no ground to believe that only one of the reactions shown in Fig. 4 occurs
when a cell is irradiated and excited electronic states are promoted. The question is,
which mechanism is decisive. It is not excluded that all mechanisms shown in Fig. 4
lead to a similar result, to a modulation of redox state of the mitochondria (a shift to
more oxidized direction). However, depending on the light dose and intensity used,
some mechanism(s) can prevail significantly [5].
The next question is, the following if photoacceptors are located in the mitochondria,
then how the primary reactions occurring under irradiation in the respiratory chain
(Fig. 4) are connected with DNA and RNA synthesis in the nucleus (the action spectra
in Fig. 2A, B) or with changes in plasma membrane (Fig. 2C)? The principal answer is
that between these events there are secondary (dark) reactions (cellular signaling
cascades or photosignal transduction and amplification, Fig. 5).
Three regulation pathways are suggested in Fig. 4. The first one is the control of
photoacceptor over the level of intracellular ATP. It is known tat even small changes in
ATP level can alter cellular metabolism significantly. This regulation way is especially
important by irradiation of hypoxic, starving or otherways stressed cells. However, in
many cases the regulative role of redox homeostasis is proved to be more important
than that of ATP. For example, it is known that the susceptibility of cells to hypoxic
injury depends more on the capacity of cells to maintain the redox homeostasis and less
on their capacity to maintain the energy status.
The second and third regulation pathways are mediated through the cellular redox state
(Eh; Fig. 4). This way involve redox-sensitive transcription factors (NF-KB and AP1,
Fig. 4) or cellular signaling homeostatic cascades from cytoplasma via cells membrane
to the nucleus (Fig. 4). As a whole, the scheme in Fig. 4 suggests a shift in overcell
redox potential into more oxidized direction. Modulation of cellular redox state affects
gene expression namely via transcription factors. It is important that in spite of some
similar or even identical steps in cellular signaling, the final cellular responses to the
irradiation differ due to existence of different modes of regulation of transcription
factors. The mechanisms of regulation are not understood well yet.
The magnitude of cellular responses depends on cellular redox potential (and its
physiological status, respectively) at the moment of irradiation. The cellular response is
stronger when the redox potential of the target cell is initially shifted to a more reduced
state (and intracellular pH, pH;, is lowered, as usually happens in injured cells). This
explains why the degrees of cellular responses can differ markedly in different
experiments or in different clinical cases, and why the effects are sometimes
nonexistent.
One should emphasize that some biological limitations exist for photobiomodulation
effects. These are discussed in [5].
The redox regulation mechanism cannot occur solely via respiratory chain (Section 3).
Other redox chains containing molecules, which absorb light in visible-to-near IR
radiation, and are some key structures that can regulate a metabolic pathway, can be
photoacceptors for photobiomodulation as well. One such example is NADPH-oxidase
of phagocytic cells, which is responsible for nonmitochondrial respiratory burst. This
multicomponent enzyme system located in the plasma membrane is a redox chain that
generates reactive oxygen species (ROS) as a response to the microbicidal or other
types of activation. Irradiation with He-Ne laser and diode lasers and LED's can
activate this chain in various phagocytic cells. Many worked examples can be found in
[5]. In phagocytes, the activation of respiratory chains in mitochondria occurs as well,
as NADHP-oxidase activation, but the latter is much stronger.
5. Concluding Remarks
Cited Literature
1. Tuner, J. and Hode, L. (1999). Low Level Laser Therapy. Clinical Practice and
Scientific Background. Prima Books, Grangesberg (Sweden).
3. Simunovic, Z., editor (2000). Lasers in Medicine and Dentistry, vol. I. Vitgraf,
Rijeka (Croatia).
4. Karu, T.I. (2002). Low power laser therapy. In: CRC Biomedical Photonics
Handbook, T. Vo-Dinh, Editor- in-Chief, CRC Press, Boca Raton (USA).
5. Karu, T.I. (1998). The Science of Low Power Laser Therapy. Gordon and Breach
Sci. Publ., London.